Fda Recall Of Heart Meds Grows Due To Cancer Risk
This week Aurobindo Pharma USA announced a voluntary recall of 78 lots of valsartan tablets, and Torrent Pharmaceuticals expanded its voluntary recall of losartan potassium tablets to a total of 10 lots. The ongoing recall applies to specific angiotensin II receptor blockers (ARBs) found to have trace amounts of the chemicals N-nitrosodiethylamine (NDEA) or N-nitrosodimethylamine (NDMA) above the acceptable daily intake levels. NDEA was detected in these newly recalled drugs....